Loading clinical trials...
Loading clinical trials...
The object of this trial is to assess the safety and efficacy of a 24 week course of flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sprout Pharmaceuticals, Inc
NCT05489133 · Post Traumatic Stress Disorder, Rape Sexual Assault, and more
NCT05093647 · Sexual Dysfunctions, Psychological, High Risk Pregnancy, and more
NCT00746967 · Sexual Dysfunctions, Psychological, Sexual Arousal Disorder
NCT02593396 · Sexual Dysfunctions, Psychological, Hypoactive Sexual Desire Disorder, and more
NCT00360555 · Sexual Dysfunctions, Psychological
511.147.01074 Boehringer Ingelheim Investigational Site
Birmingham, Alabama
511.147.01046 Boehringer Ingelheim Investigational Site
Huntsville, Alabama
511.147.01042 Boehringer Ingelheim Investigational Site
Mobile, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions